Latest Articles
Science Stories
Protein Degraders: Changing the Game in Cancer Drug Discovery
Boehringer Ingelheim Scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach
Read more
Science Stories
Transforming the Treatment of Lung Fibrosis through Lung Repair and Regeneration
Matthew Thomas, Head of Immunology & Respiratory Research, Germany, describes how translational science approaches are informing our lung fibrosis research
Read more
Science Stories
Our Transformative Team Culture
The team talks about the culture at Boehringer Ingelheim.
Read more
Downloads
Our ‘Patient First’ Approach to Biotherapeutics Research
Find out how our modality-agnostic approach harnesses biology to advance novel precision medicines.